124 related articles for article (PubMed ID: 38902005)
1. Pharmacokinetic and pharmacodynamic data from the NEOLEV1 and NEOLEV2 studies.
Sharpe C; Yang DZ; Haas RH; Reiner GE; Lee L; Capparelli EV;
Arch Dis Child; 2024 Jun; ():. PubMed ID: 38902005
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of levetiracetam in neonates with seizures.
Lima-Rogel V; López-López EJ; Medellín-Garibay SE; Gómez-Ruiz LM; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
J Clin Pharm Ther; 2018 Jun; 43(3):422-429. PubMed ID: 29265480
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
[TBL] [Abstract][Full Text] [Related]
4. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life.
Sharpe CM; Capparelli EV; Mower A; Farrell MJ; Soldin SJ; Haas RH
Pediatr Res; 2012 Jul; 72(1):43-9. PubMed ID: 22495532
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Levetiracetam as Add-On Therapy in the Treatment of Seizures in Neonates.
Rondagh M; De Vries LS; Peeters-Scholte CMPCD; Tromp SC; Steggerda SJ
Neonatology; 2024; 121(2):233-243. PubMed ID: 38113859
[TBL] [Abstract][Full Text] [Related]
6. Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures.
Shin JW; Jung YS; Park K; Lee SM; Eun HS; Park MS; Park KI; Namgung R
Korean J Pediatr; 2017 Feb; 60(2):50-54. PubMed ID: 28289434
[TBL] [Abstract][Full Text] [Related]
7. A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy.
Rao LM; Hussain SA; Zaki T; Cho A; Chanlaw T; Garg M; Sankar R
Epilepsy Behav; 2018 Nov; 88():212-217. PubMed ID: 30296665
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
[TBL] [Abstract][Full Text] [Related]
9. Anti-seizure medications for neonates with seizures.
Abiramalatha T; Thanigainathan S; Ramaswamy VV; Pressler R; Brigo F; Hartmann H
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD014967. PubMed ID: 37873971
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Study of Levetiracetam and Phenobarbital for Neonatal Seizures as a First Line Treatment.
Akeel NE; Suliman HA; Al-Shokary AH; Ibrahim AO; Kamal NM; Abdelgalil AA; Elmala MK; Elshorbagy HH; Nasef KA; Attia AM; Fathallah MGED
Glob Pediatr Health; 2022; 9():2333794X221143572. PubMed ID: 36578326
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, drug interactions and exposure-response relationship of eslicarbazepine acetate in adult patients with partial-onset seizures: population pharmacokinetic and pharmacokinetic/pharmacodynamic analyses.
Falcão A; Fuseau E; Nunes T; Almeida L; Soares-da-Silva P
CNS Drugs; 2012 Jan; 26(1):79-91. PubMed ID: 22171585
[TBL] [Abstract][Full Text] [Related]
13. Response of levetiracetam in neonatal seizures.
Yau ML; Fung EL; Ng PC
World J Clin Pediatr; 2015 Aug; 4(3):45-9. PubMed ID: 26261766
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Evaluation of First-line Levetiracetam use for Neonatal Seizures after Congenital Heart Defect repair with or without Extracorporeal Membrane Oxygenation.
Keene JC; Wainwright M; Morgan LA; Mietzsch U; Musa N; Bozarth XL; Natarajan N
J Pediatr Pharmacol Ther; 2022; 27(3):254-262. PubMed ID: 35350164
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of extended-release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide.
Muñana KR; Otamendi AJ; Nettifee JA; Papich MG
J Vet Intern Med; 2018 Sep; 32(5):1677-1683. PubMed ID: 30238679
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial.
Favrais G; Ursino M; Mouchel C; Boivin E; Jullien V; Zohar S; Saliba E
BMJ Open; 2019 Jan; 9(1):e022739. PubMed ID: 30679288
[TBL] [Abstract][Full Text] [Related]
17. Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures.
Lee YJ; Yum MS; Kim EH; Ko TS
Korean J Pediatr; 2016 Jan; 59(1):35-9. PubMed ID: 26893602
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core study.
Onos KD; Quinney SK; Jones DR; Masters AR; Pandey R; Keezer KJ; Biesdorf C; Metzger IF; Meyers JA; Peters J; Persohn SC; McCarthy BP; Bedwell AA; Figueiredo LL; Cope ZA; Sasner M; Howell GR; Williams HM; Oblak AL; Lamb BT; Carter GW; Rizzo SJS; Territo PR
Alzheimers Dement (N Y); 2022; 8(1):e12329. PubMed ID: 36016830
[TBL] [Abstract][Full Text] [Related]
19. Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation.
Pokorná P; Šíma M; Vobruba V; Tibboel D; Slanař O
Perfusion; 2018 May; 33(1_suppl):80-86. PubMed ID: 29788839
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam in toxic seizures.
Lee T; Warrick BJ; Sarangarm P; Alunday RL; Bussmann S; Smolinske SC; Seifert SA
Clin Toxicol (Phila); 2018 Mar; 56(3):175-181. PubMed ID: 28753046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
